Skip to content

G&A at other companies

Macerich logo
MacerichMAC
$8.03M+5.4%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$20.36M+25.1%
ODT
Odyssey Therapeutics, Inc.ODTX
$7.35M-7.6%
ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
$58.46M-1.9%
Chord Energy logo
Chord EnergyCHRD
$37.51M-2.3%
Generate Biomedicines, Inc.
 logo
Generate Biomedicines, Inc. GENB
$13.52M+33.3%

Other financials

Income statement

See full
Revenue$67.8K-86.4%
Gross profit$3.7K-97.9%
Operating income-$4.5M+51.4%
Net income-$16.6M-77.7%
EPS (diluted)-$0.20+41.2%

Balance sheet

See full
Cash & equivalents$5.8M+671%
Total debt$970.5K
Total equity$3.3M+163%
Total assets$11.5M

Cash flow

See full
Operating cash flow-$7.5M-455%
CapEx$70.1K
Free cash flow-$7.6M

Valuation

See full
Market cap$97.82M
Enterprise value$92.99M
P/S226.3×

Profitability

See full
Gross margin24.9%
Operating margin-8,029.7%
Net margin-16,114.2%

Returns & leverage

See full
Return on equity7,086.2%
Debt / equity0.3×
Current ratio1.2×

Where this comes from

Reported directly by VenHub Global, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: VenHub Global, Inc. ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about VenHub Global, Inc. 's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is VenHub Global, Inc. 's G&A?
VenHub Global, Inc. (VHUB) reported G&A of $3.89M in Q1 2026.
How has VenHub Global, Inc. 's G&A changed year-over-year?
VenHub Global, Inc. 's G&A decreased by 55.5% year-over-year, from $8.74M to $3.89M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.